TY - JOUR
T1 - Test All for Hepatitis B Virus
T2 - Link to Care and Treatment if Quantitative DNA Positive, Vaccinate if Susceptible
AU - Roma, Katerina
AU - Dossaji, Zahra
AU - Haque, Lubaba
AU - Laeeq, Tooba
AU - Gish, Robert G.
AU - Brosgart, Carol
N1 - Copyright © 2023 Elsevier Inc. All rights reserved.
PY - 2023/11
Y1 - 2023/11
N2 - Hepatitis B infection affects approximately 262 million people worldwide and is responsible for 900,000 deaths annually. This article reviews the major factors limiting HBV elimination, which includes limited linkage to care and complicated HBV testing and treatment guidelines. The article then provides solutions to these pressing issues.
AB - Hepatitis B infection affects approximately 262 million people worldwide and is responsible for 900,000 deaths annually. This article reviews the major factors limiting HBV elimination, which includes limited linkage to care and complicated HBV testing and treatment guidelines. The article then provides solutions to these pressing issues.
KW - Emerging therapies
KW - HBV treatment
KW - Hepatitis B virus
KW - Linkage to care
KW - Triple panel testing
KW - Hepatitis B/diagnosis
KW - Humans
KW - DNA
KW - Vaccination
KW - Hepatitis B, Chronic/diagnosis
KW - Hepatitis B virus/genetics
UR - https://www.scopus.com/pages/publications/85164618434
UR - https://www.scopus.com/pages/publications/85164618434#tab=citedBy
UR - https://www.mendeley.com/catalogue/f0df0e60-f11c-3898-8dc4-f49c5af76a06/
U2 - 10.1016/j.cld.2023.05.009
DO - 10.1016/j.cld.2023.05.009
M3 - Article
C2 - 37778782
AN - SCOPUS:85164618434
SN - 1089-3261
VL - 27
SP - 997
EP - 1022
JO - Clinics in Liver Disease
JF - Clinics in Liver Disease
IS - 4
ER -